Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Selsym Biotech has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
Selsym Biotech's investors include National Institutes of Health, Center for Entrepreneurial Development, One North Carolina Small Business Program.
Selsym Biotech is headquartered in Raleigh, United States.
Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Selsym Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Selsym Biotech — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/selsym-biotech. Accessed July 19, 2026.
VCBacked. (2024). Selsym Biotech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/selsym-biotech
{{cite web |title=Selsym Biotech — Funding & Investors |url=https://www.vcbacked.co/company/selsym-biotech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated